Gabelli & Co Investment Advisers’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-196,992	Closed	-$4.12M	–	195
2016 Q3	$4.12M	Buy	+196,992	New	+$2.27M	0.48%	47

Gabelli & Co Investment Advisers's VTAE Position: Q4 2016 in Review

Gabelli & Co Investment Advisers sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 196,992 shares — an estimated $4.12M sold.

Gabelli & Co Investment Advisers first reported a position in VTAE in Q3 2016 and held it in 1 quarter. The position peaked at $4.12M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

Gabelli & Co Investment Advisers reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 196,992 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $4.12M.
Gabelli & Co Investment Advisers first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2016 and held it in 1 quarter.
Gabelli & Co Investment Advisers's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $4.12M in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2016, filed 10 Feb 2017.